Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alx Oncology Holdings Inc
(NQ:
ALXO
)
2.580
-0.060 (-2.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alx Oncology Holdings Inc
< Previous
1
2
3
4
5
Next >
Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 08, 2023
Shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) moved lower during Friday’s session following weak quarterly earnings.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 08, 2023
Via
Benzinga
Torrid Reports Upbeat Results, Joins MBIA, Virco Mfg. And Other Big Stocks Moving Higher On Friday
December 08, 2023
U.S. stocks traded mostly higher, with the Dow Jones index gaining more than 40 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Where ALX Oncology Holdings Stands With Analysts
December 08, 2023
Via
Benzinga
The Latest Analyst Ratings for ALX Oncology Holdings
November 14, 2023
Via
Benzinga
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces November Investor Conference Participation
November 01, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 10, 2023
From
ALX Oncology
Via
GlobeNewswire
The Latest Analyst Ratings for ALX Oncology Holdings
October 04, 2023
Via
Benzinga
Why ALX Oncology Stock Is Skyrocketing Today
October 03, 2023
Investors are cheering the immuno-oncology company's latest clinical trial results.
Via
The Motley Fool
Where ALX Oncology Holdings Stands With Analysts
September 07, 2023
Via
Benzinga
What's Going On With ALX Oncology Stock?
October 05, 2023
ALX Oncology Holdings Inc (NASDAQ: ALXO) shares are trading higher by 5.9% to $6.76 Thursday morning. The company announced the pricing of a public offering consisting of roughly 7.37 million common...
Via
Benzinga
ALX Oncology Announces Pricing of Public Offering
October 05, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Proposed Public Offering
October 04, 2023
From
ALX Oncology
Via
GlobeNewswire
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 04, 2023
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2...
Via
Benzinga
Cal-Maine Foods, A10 Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 04, 2023
U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Crude Oil Moves Higher; POINT Biopharma Global Shares Jump
October 03, 2023
U.S. stocks extended losses toward the end of trading, with the S&P 500 falling around 1.5% on Tuesday. The Dow traded down 1.43% to 32,954.84 while the NASDAQ fell 1.98% to 13,044.24. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 03, 2023
Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 03, 2023
Via
Benzinga
ALX Oncology Holdings Inc. (NASDAQ: ALXO) is One of Tuesday Morning’s Most Active Stocks
October 03, 2023
Via
Investor Brand Network
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
October 03, 2023
Benzinga
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 03, 2023
Via
Benzinga
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
October 03, 2023
ALX Oncology Holdings Inc (NASDAQ: ALXO) released prespecified interim Phase 2 data from its ASPEN-06 trial of evorpacept plus trastuzumab, Cyramza (ramucirumab) and paclitaxel for HER2-positive...
Via
Benzinga
Why Delta Apparel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 03, 2023
Gainers VIQ Solutions Inc. (NASDAQ: VQS) shares rose 88.5% to $0.2470 in pre-market trading after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq.
Via
Benzinga
S&P 500, Nasdaq Futures Waver As Focus Turns To JOLTS Data: Why These Analysts Say Expecting A Strong Q4 This Year Is 'Tricky'
October 03, 2023
Index futures point to a modestly higher opening on Tuesday, while 10-year Treasury yields have surged to over 4.70%, adding to uncertainty about interest rates.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
October 03, 2023
From
ALX Oncology
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
October 02, 2023
Via
Benzinga
ALX Oncology to Host Investor Call and Webcast on October 3, 2023 to Share Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
October 02, 2023
From
ALX Oncology
Via
GlobeNewswire
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
Via
Investor Brand Network
Exposures
Product Safety
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.